ACRS - Aclaris Therapeutics, Inc.
4.88
-0.070 -1.434%
Share volume: 948,792
Last Updated: 05-12-2026
Pharmaceutical Products/Pharmaceutical Preparations:
0.10%
PREVIOUS CLOSE
CHG
CHG%
$4.95
-0.07
-0.01%
Summary score
46%
Profitability
35%
Dept financing
34%
Liquidity
50%
Performance
60%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2022 - 2026
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-12.6%
Return on sales
-847.67%
Return on invested capital
0%
Total debt ratio
26%
Debt ratio change over timeo
0%
Current Ratio
5.76%
Quick Ratio
0%
Cash Position Ratio
1.45%
Short-term ratios 2025 - 2026
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-11.21%
Return on sales
-1105.77%
Return on invested capital
0%
Total debt ratio
31.35%
Debt ratio change over timeo
0%
Current Ratio
3.8%
Quick Ratio
0%
Cash Position Ratio
0.92%
Last quarter ratios 2026
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-11.17%
Return on sales
-1111.82%
Return on invested capital
0%
Total debt ratio
27.71%
Debt ratio change over time
0%
Current Ratio
4.03%
Quick Ratio
0%
Cash Position Ratio
1.05%
Performance ratios (change over 4 years) 2022 - 2026
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ACRS | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 10.6% | 11.11% | 0% |
| Return on assets | -12.6% | 4.87% | 3.15% | 0% |
| Return on sales | -847.67% | 31.64% | 25.21% | 0% |
| Return on invested capital | 0% | 7.36% | 11.75% | 0% |
| Profitability | 0% | 90% | 86% | 0% |
| Total debt ratio | 26% | 79.95% | 59.47% | 0% |
| Debt ratio change over time | 0% | -25.01% | -101.26% | 0% |
| Dept financing | 33% | 25% | 19% | 0% |
| Current Ratio | 3.8% | 1.47% | 1.03% | 0% |
| Quick Ratio | 0% | 1.13% | 0.77% | 0% |
| Cash Position Ratio | 0.92% | 0.17% | 0.36% | 0% |
| Liquididy | 50% | 33% | 36% | 0% |
| Short-term ratios | ACRS | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -11.21% | 6.99% | 3.19% | 0% |
| Return on sales | -1105.77% | 43.61% | 26.42% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 27% | 0% |
| Total debt ratio | 31.35% | 77.72% | 59.24% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 35% | 25% | 19% | 0% |
| Current Ratio | 3.8% | 1.47% | 1.03% | 0% |
| Quick Ratio | 0% | 1.13% | 0.77% | 0% |
| Cash Position Ratio | 0.92% | 0.17% | 0.36% | 0% |
| Liquididy | 50% | 39% | 34% | 0% |